Gadodiamide Pregnancy and Breastfeeding Warnings
Medically reviewed by Drugs.com. Last updated on Oct 20, 2022.
Gadodiamide is also known as: Omniscan
Gadodiamide Pregnancy Warnings
Gadodiamide has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Gadodiamide is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.
Gadodiamide Breastfeeding Warnings
There are no data on the excretion of gadodiamide into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering gadodiamide to nursing women.
See also
References for pregnancy information
- "Product Information. Omniscan (gadodiamide)." Novation (2004):
References for breastfeeding information
- "Product Information. Omniscan (gadodiamide)." Novation (2004):
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
